Home › Funds › ACT CAPITAL MANAGEMENT, LLC › KRYS
ACT CAPITAL MANAGEMENT, LLC position in KRYS
KRYSTAL BIOTECH INC · Health Care
ACT CAPITAL MANAGEMENT, LLC reported holding 45,000 shares of KRYS (KRYSTAL BIOTECH INC) in its Q2 2026 13F filing — a position valued at US$16.7M, representing 10.93% of its reported portfolio and ranking #1 among its reported holdings. ACT CAPITAL MANAGEMENT, LLC has disclosed KRYS holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How ACT CAPITAL MANAGEMENT, LLC's KRYS position evolved
ACT CAPITAL MANAGEMENT, LLC first disclosed a stake in KRYS in Q4 2025 at 60,500 shares (US$14.9M). The position peaked in Q2 2026 at 45,000 shares, worth US$16.7M. Across 3 filings, ACT CAPITAL MANAGEMENT, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 45,000 shares valued at US$16.7M — a reduction of -15,477 shares quarter over quarter.. Notable position changes include a 26% trim in Q2 2026 (shares fell 11% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 60.50K | $14.92M | New |
| Q1 2026 | 60.48K | $15.62M | Hold |
| Q2 2026 | 45.00K | $16.73M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About KRYS and 13F data
KRYS (KRYSTAL BIOTECH INC) is a Health Care company. 49 other funds we track also report a position in KRYS — the largest reported positions include Avoro Capital Advisors LLC (US$1.07B), Soleus Capital Management, L.P. (US$349.1M), Hood River Capital Management LLC (US$246.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding KRYS
- Avoro Capital Advisors LLC 2.89M sh · $1.07B · Q2 2026
- Soleus Capital Management, L.P. 939.25K sh · $349.09M · Q2 2026
- Hood River Capital Management LLC 663.38K sh · $246.56M · Q2 2026
- Redmile Group, LLC 632.00K sh · $234.90M · Q2 2026
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 570.15K sh · $211.91M · Q2 2026
- Frazier Life Sciences Management, L.P. 481.31K sh · $178.89M · Q2 2026
- VESTOR CAPITAL, LLC 700.91K sh · $78.19M · Q2 2026
- BRAIDWELL LP 128.97K sh · $47.94M · Q2 2026
More on ACT CAPITAL MANAGEMENT, LLC
FAQ
How long has ACT CAPITAL MANAGEMENT, LLC held KRYS?
ACT CAPITAL MANAGEMENT, LLC has disclosed KRYS holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is ACT CAPITAL MANAGEMENT, LLC's current position in KRYS?
As of Q2 2026, ACT CAPITAL MANAGEMENT, LLC holds 45.00K shares of KRYS (KRYSTAL BIOTECH INC), valued at $16.73M, representing 10.93% of its reported portfolio and ranking #1.
Has ACT CAPITAL MANAGEMENT, LLC been buying or selling KRYS?
In the latest 13F filing (Q2 2026), ACT CAPITAL MANAGEMENT, LLC reduced its position in KRYS. The position peaked in Q2 2026 at 45.00K shares.
Which other funds hold KRYS?
Other major institutional holders of KRYS include Avoro Capital Advisors LLC, Soleus Capital Management, L.P., Hood River Capital Management LLC, among 49 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.